Montreal, Canada

Krishna G Peri


 

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 74(Granted Patents)


Location History:

  • Montréal, CA (2001 - 2005)
  • St-Laurent, CA (2006 - 2009)
  • Saint-Laurent, CA (2009 - 2015)
  • Ville Saint-Laurent, CA (2016)
  • Montreal, CA (1999 - 2021)

Company Filing History:


Years Active: 1999-2021

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Innovations of Krishna G Peri

Introduction

Krishna G Peri is a notable inventor based in Montreal, Canada, recognized for his significant contributions to the field of bioactive peptides. With a total of 16 patents to his name, he has made remarkable advancements that have implications in medical science and therapeutic applications.

Latest Patents

One of his latest patents is titled "Pegylated bioactive peptides and uses thereof." This patent describes bioactive peptides that are modified at one or more positions with a PEG moiety. An example of such a PEGylated bioactive peptide is a GHRH analog that is modified at one or more positions with a PEG moiety. The patent also discusses pharmaceutically acceptable salts and pharmaceutical compositions comprising such analogs or salts. Furthermore, it outlines methods, kits, and uses for inducing or stimulating growth hormone secretion in a subject, as well as for diagnosing, preventing, or treating GH-deficient conditions.

Career Highlights

Throughout his career, Krishna G Peri has worked with prominent organizations such as Theratechnologies Inc. and Université de Montréal. His work has been instrumental in advancing the understanding and application of bioactive peptides in therapeutic settings.

Collaborations

Some of his notable coworkers include Sylvain Chemtob and Abdelkrim Habi, who have collaborated with him on various projects and research initiatives.

Conclusion

Krishna G Peri's innovative work in the field of bioactive peptides has led to significant advancements in medical science. His contributions continue to influence the development of therapies for growth hormone deficiencies and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…